Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant expression systems in the pharmaceutical industry.

F R Schmidt1

  • 1Aventis Pharma Deutschland, Biocenter H 780, Industriepark Höchst, 65926, Frankfurt am Main, Germany. frank-rainer.schmidt@aventis.com

Applied Microbiology and Biotechnology
|October 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of dermatoses with vasodilators.

Archives of dermatology and syphilology·2010
Same author

Chronic discoid lupus erythematosus.

Archives of dermatology and syphilology·2010
Same author

Lupus erythematosus treated with vasodilators and colloidal gold sulfide.

Archives of dermatology and syphilology·2010
Same author

Subacute lupus erythematosus.

Archives of dermatology and syphilology·2010
Same author

The RNA interference-virus interplay: tools of nature for gene modulation, morphogenesis, evolution and a possible mean for aflatoxin control.

Applied microbiology and biotechnology·2009
Same author

Optimization and scale up of industrial fermentation processes.

Applied microbiology and biotechnology·2005

Secretory expression systems offer advantages for recombinant protein production but require optimization for high yields. Strategies include enhancing gene expression and improving host systems like Escherichia coli and Bacillus species.

Area of Science:

  • Biotechnology
  • Protein Engineering
  • Molecular Biology

Background:

  • Secretory expression systems offer advantages in downstream processing for recombinant protein production compared to cytosolic systems.
  • Current secretory systems struggle to achieve competitive yields for high-volume therapeutics like insulin.
  • Optimization strategies are crucial for enhancing protein production and secretion efficiency.

Purpose of the Study:

  • To review and discuss strategies for improving the efficiency of secretory expression systems for recombinant protein production.
  • To evaluate the suitability of different host organisms, including prokaryotes, fungi, insect, and mammalian cells, for specific protein production needs.
  • To highlight the importance of understanding posttranslational modifications for optimizing protein folding and secretion.

Related Experiment Videos

Main Methods:

  • Review of current strategies for enhancing gene expression, optimizing signal sequences, and utilizing chaperones and foldases.
  • Analysis of protease-deficient mutants to prevent premature protein degradation.
  • Discussion of host system selection, including Escherichia coli, Bacillus species, fungal, insect, and mammalian cells.
  • Exploration of genetic engineering and mutagenesis approaches for strain improvement.

Main Results:

  • Prokaryotes, such as Escherichia coli and Bacillus species, are suitable for non-glycosylated proteins due to their lack of glycosylation pathways.
  • Fungal species require deeper understanding of glycosylation for optimizing folding and secretion.
  • Insect and mammalian cells are suitable for proteins requiring human-like posttranslational modifications, despite higher costs.

Conclusions:

  • Improving secretory expression systems is vital for competitive recombinant protein production, especially for therapeutics.
  • Host system selection and optimization of posttranslational modifications are key factors for successful protein production.
  • Further research into glycosylation pathways and host engineering is needed to fully exploit secretory capacities.